Insight Molecular Diagnostics Inc. Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax
Insight Molecular Diagnostics Inc. (IMDX) reported Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax of -$6.49 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest · last filed 2023-11-09
- Insight Molecular Diagnostics Inc. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2023-09-30 was -$6.49M.
- Insight Molecular Diagnostics Inc. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2023-06-30 was -$8.33M.
- Insight Molecular Diagnostics Inc. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2022-09-30 was -$9.33M.
- Insight Molecular Diagnostics Inc. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2022-06-30 was -$8.30M.
| Period end | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 3 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 6 month | Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 9 month |
|---|---|---|---|
| 2023-09-30 | -$6.49M 10-Q · filed 2023-11-09 | -$14.82M derived: sum of 2 quarters · filed 2023-11-09 | -$11.79M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$8.33M 10-Q · filed 2023-08-10 | -$5.30M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | -$9.33M 10-Q · filed 2023-11-09 | -$17.63M derived: sum of 2 quarters · filed 2023-11-09 | -$27.92M 10-Q · filed 2023-11-09 |
| 2022-06-30 | -$8.30M 10-Q · filed 2023-08-10 | -$18.59M 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |